Sarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: review

Over the past decade, there has been a noticeable increase in the number of publications devoted to the analysis of body composition in the treatment of gastrointestinal malignancies. Sarcopenia (skeletal muscle depletion), sarcopenic obesity and myosteatosis are shown to have a negative impact on t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tatyana S. Dikova, Alina Y. Zatsepina, Denis S. Fedorinov, Vladimir K. Lyadov
Formato: article
Lenguaje:RU
Publicado: IP Habib O.N. 2021
Materias:
Acceso en línea:https://doaj.org/article/811910c2d8eb4c51a68d8224065c2f45
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:811910c2d8eb4c51a68d8224065c2f45
record_format dspace
spelling oai:doaj.org-article:811910c2d8eb4c51a68d8224065c2f452021-11-30T16:55:01ZSarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: review1815-14341815-144210.26442/18151434.2021.1.200715https://doaj.org/article/811910c2d8eb4c51a68d8224065c2f452021-05-01T00:00:00Zhttps://modernonco.orscience.ru/1815-1434/article/viewFile/70461/51388https://doaj.org/toc/1815-1434https://doaj.org/toc/1815-1442Over the past decade, there has been a noticeable increase in the number of publications devoted to the analysis of body composition in the treatment of gastrointestinal malignancies. Sarcopenia (skeletal muscle depletion), sarcopenic obesity and myosteatosis are shown to have a negative impact on the results of surgical and chemotherapeutic treatment of patients with gastrointestinal tumors. The review presents in detail data on clinical value of sarcopenia, sarcopenic obesity and myosteatosis along with methodological aspects of body composition analysis. Different cut-offs and diagnostic criteria exist between Western and Eastern patient populations which makes any comparison or meta-analysis not possible right now. The review presents data from Russian and foreign studies on the influence of body composition on postoperative outcomes and survival in patients with gastrointestinal tumors. The article also discusses the influence of body composition on dose-limiting toxicity of chemotherapy. We aimed at raising awareness of clinicians regarding the high prevalence of cancer cachexia and, precisely, sarcopenia, sarcopenic obesity and myosteatosis in patients with GI tract tumors. Deeper understanding of these syndromes is the key to developing measures for prevention as well as correcting the treatment of patients with gastrointestinal tumors.Tatyana S. DikovaAlina Y. ZatsepinaDenis S. FedorinovVladimir K. LyadovIP Habib O.N.articlecachexiasarcopeniasarcopenic obesitymyosteatosiscancergastro-intestinal tractNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282RUСовременная онкология, Vol 23, Iss 1, Pp 141-147 (2021)
institution DOAJ
collection DOAJ
language RU
topic cachexia
sarcopenia
sarcopenic obesity
myosteatosis
cancer
gastro-intestinal tract
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle cachexia
sarcopenia
sarcopenic obesity
myosteatosis
cancer
gastro-intestinal tract
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Tatyana S. Dikova
Alina Y. Zatsepina
Denis S. Fedorinov
Vladimir K. Lyadov
Sarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: review
description Over the past decade, there has been a noticeable increase in the number of publications devoted to the analysis of body composition in the treatment of gastrointestinal malignancies. Sarcopenia (skeletal muscle depletion), sarcopenic obesity and myosteatosis are shown to have a negative impact on the results of surgical and chemotherapeutic treatment of patients with gastrointestinal tumors. The review presents in detail data on clinical value of sarcopenia, sarcopenic obesity and myosteatosis along with methodological aspects of body composition analysis. Different cut-offs and diagnostic criteria exist between Western and Eastern patient populations which makes any comparison or meta-analysis not possible right now. The review presents data from Russian and foreign studies on the influence of body composition on postoperative outcomes and survival in patients with gastrointestinal tumors. The article also discusses the influence of body composition on dose-limiting toxicity of chemotherapy. We aimed at raising awareness of clinicians regarding the high prevalence of cancer cachexia and, precisely, sarcopenia, sarcopenic obesity and myosteatosis in patients with GI tract tumors. Deeper understanding of these syndromes is the key to developing measures for prevention as well as correcting the treatment of patients with gastrointestinal tumors.
format article
author Tatyana S. Dikova
Alina Y. Zatsepina
Denis S. Fedorinov
Vladimir K. Lyadov
author_facet Tatyana S. Dikova
Alina Y. Zatsepina
Denis S. Fedorinov
Vladimir K. Lyadov
author_sort Tatyana S. Dikova
title Sarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: review
title_short Sarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: review
title_full Sarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: review
title_fullStr Sarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: review
title_full_unstemmed Sarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: review
title_sort sarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: review
publisher IP Habib O.N.
publishDate 2021
url https://doaj.org/article/811910c2d8eb4c51a68d8224065c2f45
work_keys_str_mv AT tatyanasdikova sarcopeniasarcopenicobesitymyosteatosisasfactorsofpoorprognosisingastrointestinaltracttumorsreview
AT alinayzatsepina sarcopeniasarcopenicobesitymyosteatosisasfactorsofpoorprognosisingastrointestinaltracttumorsreview
AT denissfedorinov sarcopeniasarcopenicobesitymyosteatosisasfactorsofpoorprognosisingastrointestinaltracttumorsreview
AT vladimirklyadov sarcopeniasarcopenicobesitymyosteatosisasfactorsofpoorprognosisingastrointestinaltracttumorsreview
_version_ 1718406454600269824